|
Remus Pharmaceuticals IPO subscribed 57.21 times. The public issue subscribed 49.81 times in the retail category, 10.75 times in QIB, and 229.31 times in the NII category by May 19, 2023.
Investor Category | Subscription (times) | Shares Bid for | Total Amount (Rs Cr.)* |
---|---|---|---|
Qualified Institutions | 10.75 | 14,92,000 | 183.37 |
Non-Institutional Buyers | 229.31 | 95,45,000 | 1,173.08 |
Retail Investors | 49.81 | 48,37,600 | 594.54 |
Employees | [.] | 0 | 0 |
Others | [.] | 0 | 0 |
Total | 57.21 | 1,58,74,600 | 1,950.99 |
Total Application : 48,376 (49.77 times)
Disclaimer: *The total amount is calculated based on the final issue price or the price in the upper price range.
Date | QIB | NII | Retail | Total |
---|---|---|---|---|
Day 1 May 17, 2023 | 0.00 | 2.85 | 2.85 | 1.43 |
Day 2 May 18, 2023 | 1.48 | 12.25 | 10.93 | 6.41 |
Day 3 May 19, 2023 | 10.75 | 229.31 | 49.81 | 57.21 |
Remus Pharmaceuticals IPO is a public issue of 277,500 equity shares. The issue offers 97,125 shares to retail investors, 138,750 shares to qualified institutional buyers, and 41,625 shares to non-institutional investors.
Category | Shares Offered | Amount (Rs Cr) | Size (%) |
---|---|---|---|
QIB | 138,750 | 17.05 | 50.00% |
NII | 41,625 | 5.12 | 15.00% |
Retail | 97,125 | 11.94 | 35.00% |
Total* | 277,500 | 34.10 | 100% |
* Market maker portion is not included.
Financial Institutions, Banks, FIIs, and Mutual Funds registered with SEBI are called QIBs. In most cases, QIBs represent small investors who invest through mutual funds, ULIP schemes of insurance companies, and pension schemes.
Retail Individual Investors (HNI), NRIs, Companies, Trusts, etc who bid for shares worth more than Rs 2 lakhs are known as Non-institutional bidders (NII). Unlike QIB bidders, they do not need SEBI registration.
NII category has two subcategories:
The Small NII category is for NII investors who bid for shares between Rs 2 lakhs to Rs 10 lakhs. The 1/3 of NII category shares are reserved for the Small NII sub-category. This subcategory is also known as Small HNI (sHNI).
The Big NII category is for NII investors who bid for shares worth more than Rs 10 Lakhs. The 2/3 of NII category shares are reserved for the Big NII subcategory. This subcategory is also known as Big HNI (bHNI).
The retail individual investor or NRIs who apply up to Rs 2 lakhs in an IPO are considered as RII reserved category.
A category of eligible employees who have a reserved quota in the IPO.
A category of eligible shareholders or other investors who have a reserved quota in the IPO.
What is the difference between RII, NII, QIB and Anchor Investor?
Disclaimer: The subscription data is taken from the NSE and BSE websites. They are subject to change on a real-time basis. The subscription data provided are for information purposes only and provided by Chittorgarh.com on an 'AS IS' and 'AS AVAILABLE' basis and without warranty, express or implied. Our website does not guarantee or warrant the accuracy, adequacy, or completeness of the information received through the said websites. Chittorgarh.com holds no responsibility of any kind as regards any discrepancies, errors, omissions, losses, or damages. Chittorgarh.com including its affiliates and any of its directors, and employees, shall not be liable for any loss, or damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising from the use of data received. The recipient alone shall be fully responsible / are liable for any decision taken based on such information/data. All recipients should before acting upon the said information make their investigation, and seek appropriate professional advice.
The Remus Pharmaceuticals IPO is subscribed 57.21 by May 19, 2023.
Investor Category | Subscription (times) |
---|---|
Qualified Institutional | 10.75 |
Non Institutional | 229.31 |
Retail Individual | 49.81 |
Employee Reservations | [.] |
Others | [.] |
Total Subscription | 57.21 |
An investor can apply in Remus Pharmaceuticals IPO online via bank (using ASBA) or the broker (using UPI). The Remus Pharmaceuticals IPO shares are offered online only.
The Remus Pharmaceuticals IPO is subscribed 57.21 by May 19, 2023.
The Remus Pharmaceuticals IPO allotment status is expected on or around May 24, 2023. Visit Remus Pharmaceuticals IPO allotment status to check.
Visit Remus Pharmaceuticals IPO subscription status page for real-time bidding information about Remus Pharmaceuticals IPO.
IPO Opens On | May 17, 2023 |
IPO Closes On | May 19, 2023 |
Finalisation of Basis of Allotment | May 24, 2023 |
Initiation of Refunds | May 25, 2023 |
Credit of Shares to Demat Account | May 26, 2023 |
IPO Listing Date | May 29, 2023 |
Useful Articles
FREE Account Opening (₹0)
FREE Intraday Trading (Eq, F&O)
30 days brokerage free trading
Free - Relationship Manager
Free - Classroom Training
|